Naloxon B. Braun (Naloxone Hydrochloride)

Naloxone, the active ingredient in Naloxon B. Braun, is an opioid antagonist presented as an injectable for intramuscular and intravenous use. It reverses opioid‑induced respiratory depression in emergency situations.

GNH USA supplies Naloxon B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naloxone is an opioid antagonist used in the management of opioid‑related emergencies. It acts on the opioid pathway to rapidly restore normal breathing and consciousness. - Opioid overdose: rapid reversal of respiratory depression and loss of consciousness. - Opioid toxicity: restores normal ventilation and alertness. - Opioid‑induced sedation: helps regain normal mental status.

Naloxone may cause a range of adverse reactions, most of which are related to abrupt opioid withdrawal or direct pharmacologic effects.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional emesis after administration. - Sweating: increased perspiration. - Tachycardia: elevated heart rate. - Hypertension: transient rise in blood pressure. - Headache: mild to moderate headache. - Agitation: restlessness or anxiety.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm. - Pulmonary edema: fluid accumulation in the lungs. - Seizures: rare convulsive episodes. - Severe hypertension: marked increase in blood pressure. - Anaphylaxis: acute allergic reaction requiring immediate treatment. - Acute withdrawal syndrome: severe opioid withdrawal symptoms.

Naloxone should be used with careful clinical assessment and monitoring. - Assess airway: ensure patency before administration. - Monitor vital signs: observe respiratory rate, heart rate, and blood pressure continuously. - Confirm indication: give only when opioid overdose is suspected. - Hypersensitivity: avoid in patients with known allergy to naloxone or formulation components. - Cardiovascular disease: use cautiously in patients with pre‑existing heart conditions. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Naloxone may interact with other medications that affect the central nervous system or cardiovascular system.

Major Interactions (Avoid): - Concurrent opioid antagonists: may precipitate severe withdrawal. - High‑dose opioid therapy: can cause abrupt reversal leading to life‑threatening withdrawal.

Moderate Interactions (Monitor Closely): - Sedatives or benzodiazepines: may enhance CNS depression after reversal. - MAO inhibitors: potential for hypertensive episodes. - Adrenergic agents (e.g., epinephrine): may increase risk of hypertension. - Beta‑blockers: may mask tachycardia induced by naloxone.